Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    15168363 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed COMMIT (Combination Of Maintenance Methotrexate-Infliximab Trial)
Condition: Crohn's Disease
Interventions: Drug: Methotrexate;   Drug: Placebo
2 Recruiting Correlation of Infliximab Levels With Outcomes in Ulcerative Colitis
Conditions: Colitis, Ulcerative;   Inflammatory Bowel Disease;   IBD
Intervention:
3 Active, not recruiting Fecal Microbiota Transplantation (FMT) in the Management of Ulcerative Colitis (UC)
Condition: Ulcerative Colitis
Intervention: Biological: Fecal Microbiota Transplantation

Study has passed its completion date and status has not been verified in more than two years.